Phaseline

Companies › ULURU

ULURU: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 4; Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Altrazeal (R) Transforming Powder Dressing (TPD)
Wound dressing device for burn treatment
–Phase 4Wounds and Injuries–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05424354Altrazeal (R) Transforming Powder Dressing (TPD)Phase 4Wounds and InjuriesOtherJun 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Aesculap Biologics Metcela OHB Pediatrics CoNextions Medical DiscGenics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.